Hamlin Capital Management, LLC Increases Stake in CVS Health Corporation (CVS) by 13.6%
Hamlin Capital Management, LLC, a registered investment adviser, increased its position in CVS Health Corporation (NYSE:CVS) by 13.6% during Q3 2026, according to its most recent…
CVS Health Corporation (NYSE:CVS) · position increase
Institution
Hamlin Capital Management, LLC
Institution type
investment_adviser
Reporting period
Q3 2026
Shares
1,951,402
Position value
$167.2M
Position change
13.61%
At a glance
Key takeaways
01Hamlin Capital Management increased its CVS Health stake by 13.6% in Q3 2026, adding 233,794 shares for a total position of 1.95 million shares worth $167.2 million.
02CVS Health trades at $86.70 per share with a $102.6 billion market capitalization.
03Institutional investors typically increase positions when they believe stocks have upside potential or company fundamentals have improved.
0413F filings reflect holdings as of quarter-end and are filed up to 45 days later, so positions may have changed since the filing date.
Filing Details
Hamlin Capital Management, LLC, a registered investment adviser, increased its position in CVS Health Corporation (NYSE:CVS) by 13.6% during Q3 2026, according to its most recent 13F filing with the Securities and Exchange Commission.
The firm purchased an additional 233,794 shares of the Healthcare company, bringing its total holdings to 1,951,402 shares valued at approximately $167.2M as of the filing date.
Market Context
CVS Health Corporation's stock currently trades at $86.70 with a market capitalization of $102.6B.
An increase in an existing position suggests Hamlin Capital Management, LLC has growing conviction in CVS Health Corporation's trajectory. Institutional investors typically add to positions when they believe the stock still has upside relative to their price target, or when the company's fundamentals have improved since their initial purchase.
Healthcare stocks have attracted institutional attention as an aging population drives long-term demand. CVS Health Corporation operates in a sector where regulatory developments and pipeline progress can significantly impact institutional positioning.
The size of this position — $167.2 million — places it among the more significant institutional holdings in CVS Health Corporation. Large positions like this can influence trading dynamics and are closely watched by market participants tracking smart money flows.
Investors should note that 13F filings reflect holdings as of the end of the reporting quarter and are filed up to 45 days later. The position may have changed since the filing date. 13F data is most useful when analyzed alongside other signals such as insider transactions, analyst ratings, and fundamental trends.
A 13F filing is a quarterly SEC report required for institutional managers with over $100 million in assets. It discloses equity holdings, providing transparency into how firms like Hamlin Capital Management, LLC position their portfolios.